MetaADEDB 2.0 @ LMMD
Trifluoperazine
(BXDAOUXDMHXPDI-UHFFFAOYSA-N)
Structure
SMILES
CN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F.Cl.Cl
Molecular Formula:
C21H26Cl2F3N3S
Molecular Weight:
480.417
Log P:
6.4904
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
35.02
CAS Number(s):
440-17-5
Synonym(s)
1.
Trifluoperazine
2.
Trifluoroperazine
3.
Triftazin
4.
Apo-Trifluoperazine
5.
Eskazine
6.
Flupazine
7.
Stelazine
8.
Terfluzine
9.
Trifluoperazine HCL
10.
Trifluoperazine Hydrochloride
11.
Trifluperazine
12.
Apo Trifluoperazine
13.
ApoTrifluoperazine
External Link(s)
MeSHD014268
PubChem Compound66064
25137853
15301951
ChEBI9710
CHEMBLCHEMBL1257040
KEGGdr:D00799
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AstheniaFAERS: 3
Canada Vigilance: 5
Canada Vigilance
US FAERS
2HeadacheFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
3Medication ErrorFAERS: 3US FAERS
4Drug dispensing errorFAERS: 2US FAERS
5Drug ineffectiveFAERS: 2US FAERS
6Incorrect dose administeredFAERS: 2US FAERS
7MalaiseFAERS: 2US FAERS
8Myocardial InfarctionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
9Abdominal discomfortFAERS: 1US FAERS
10Adverse eventFAERS: 1US FAERS
11AgitationFAERS: 1
Canada Vigilance: 7
Canada Vigilance
US FAERS
12AngioplastyFAERS: 1US FAERS
13AnxietyFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
14ArthralgiaFAERS: 1US FAERS
15BlepharospasmFAERS: 1US FAERS
16Cerebrovascular accidentFAERS: 1US FAERS
17Chest PainFAERS: 1US FAERS
18Cold sweatFAERS: 1US FAERS
19Drug exposure during pregnancyFAERS: 1US FAERS
20Drug withdrawal syndromeFAERS: 1US FAERS
21Dry skinFAERS: 1US FAERS
22FatigueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
23Feeling abnormalFAERS: 1US FAERS
24Incorrect product administration durationFAERS: 1US FAERS
25Intercepted drug dispensing errorFAERS: 1US FAERS
26Lip swellingFAERS: 1US FAERS
27MyalgiaFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
28NauseaFAERS: 1
Canada Vigilance: 4
Canada Vigilance
US FAERS
29Product availability issueFAERS: 1US FAERS
30Product use in unapproved indicationFAERS: 1US FAERS
31StressFAERS: 1US FAERS
32Abdominal PainCanada Vigilance: 1Canada Vigilance
33Accidental overdoseCanada Vigilance: 1Canada Vigilance
34Adjustment disorder with depressed moodCanada Vigilance: 1Canada Vigilance
35AgranulocytosisCanada Vigilance: 2Canada Vigilance
36AkathisiaCanada Vigilance: 18Canada Vigilance
37AkinesiaCanada Vigilance: 2Canada Vigilance
38Alpha-2 macroglobulin increasedCanada Vigilance: 1Canada Vigilance
39AngioedemaCanada Vigilance: 3Canada Vigilance
40ApathyCanada Vigilance: 4Canada Vigilance
41AtaxiaCanada Vigilance: 4Canada Vigilance
42CatatoniaCanada Vigilance: 2Canada Vigilance
43Cerebral PalsyCanada Vigilance: 1Canada Vigilance
44Chest discomfortCanada Vigilance: 1Canada Vigilance
45ChokingCanada Vigilance: 1Canada Vigilance
46Cogwheel RigidityCanada Vigilance: 1Canada Vigilance
47ConstipationCanada Vigilance: 4Canada Vigilance
48Conversion disorderCanada Vigilance: 1Canada Vigilance
49CyanosisCanada Vigilance: 1Canada Vigilance
50DermatitisCanada Vigilance: 1Canada Vigilance
51DizzinessCanada Vigilance: 6Canada Vigilance
52DysarthriaCanada Vigilance: 6Canada Vigilance
53DysphoniaCanada Vigilance: 3Canada Vigilance
54DystoniaCanada Vigilance: 16Canada Vigilance
55Emotional disorderCanada Vigilance: 1Canada Vigilance
56Emotional distressCanada Vigilance: 1Canada Vigilance
57EpilepsyCanada Vigilance: 1Canada Vigilance
58Erectile dysfunctionCanada Vigilance: 1Canada Vigilance
59ErythemaCanada Vigilance: 2Canada Vigilance
60Facial paralysisCanada Vigilance: 2Canada Vigilance
61Feeling jitteryCanada Vigilance: 2Canada Vigilance
62FlushingCanada Vigilance: 1Canada Vigilance
63GastritisCanada Vigilance: 1Canada Vigilance
64GlossitisCanada Vigilance: 2Canada Vigilance
65HepatitisCanada Vigilance: 1Canada Vigilance
66HyperkinesiaCanada Vigilance: 1Canada Vigilance
67HypersensitivityCanada Vigilance: 1Canada Vigilance
68HypotensionCanada Vigilance: 2Canada Vigilance
69Joint stiffnessCanada Vigilance: 2Canada Vigilance
70LethargyCanada Vigilance: 3Canada Vigilance
71LeukopeniaCanada Vigilance: 2Canada Vigilance
72Muscle RigidityCanada Vigilance: 10Canada Vigilance
73Muscle SpasticityCanada Vigilance: 2Canada Vigilance
74Muscle tightnessCanada Vigilance: 2Canada Vigilance
75Musculoskeletal PainCanada Vigilance: 1Canada Vigilance
76Musculoskeletal stiffnessCanada Vigilance: 3Canada Vigilance
77MydriasisCanada Vigilance: 1Canada Vigilance
78Neck PainCanada Vigilance: 1Canada Vigilance
79NervousnessCanada Vigilance: 2Canada Vigilance
80NystagmusCanada Vigilance: 2Canada Vigilance
81Oculogyric crisisCanada Vigilance: 6Canada Vigilance
82OpisthotonusCanada Vigilance: 9Canada Vigilance
83PainCanada Vigilance: 1Canada Vigilance
84PallorCanada Vigilance: 2Canada Vigilance
85PancytopeniaCanada Vigilance: 1Canada Vigilance
86PruritusCanada Vigilance: 1Canada Vigilance
87Rash erythematousCanada Vigilance: 1Canada Vigilance
88Reduced facial expressionCanada Vigilance: 5Canada Vigilance
89Respiratory DepressionCanada Vigilance: 1Canada Vigilance
90RestlessnessCanada Vigilance: 1Canada Vigilance
91SomnolenceCanada Vigilance: 17Canada Vigilance
92TachycardiaCanada Vigilance: 2Canada Vigilance
93Tardive DyskinesiaCanada Vigilance: 2Canada Vigilance
94TensionCanada Vigilance: 1Canada Vigilance
95TetanyCanada Vigilance: 2Canada Vigilance
96TinnitusCanada Vigilance: 2Canada Vigilance
97Tongue movement disturbanceCanada Vigilance: 1Canada Vigilance
98Tongue spasmCanada Vigilance: 1Canada Vigilance
99TorticollisCanada Vigilance: 12Canada Vigilance
100TremorCanada Vigilance: 37Canada Vigilance
101TrismusCanada Vigilance: 12Canada Vigilance
102Urinary IncontinenceCanada Vigilance: 1Canada Vigilance
103Urinary RetentionCanada Vigilance: 2Canada Vigilance
104VertigoCanada Vigilance: 1Canada Vigilance
105VomitingCanada Vigilance: 1Canada Vigilance
106jaundiceCanada Vigilance: 3Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.